Insulin, Hyperglycemia, and Severe Retinopathy of Prematurity in Extremely Low-Birth-Weight Infants

Detalhes bibliográficos
Autor(a) principal: Lee, Jan Hau
Data de Publicação: 2016
Outros Autores: Hornik, Christoph P., Testoni, Daniela [UNIFESP], Laughon, Matthew M., Cotten, C. Michael, Maldonado, Ramiro S., Belcastro, Marc R., Clark, Reese H., Smith, P. Brian
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da UNIFESP
Texto Completo: https://repositorio.unifesp.br/handle/11600/57882
http://dx.doi.org/10.1055/s-0035-1565999
Resumo: Objective This study aims to determine the association between hyperglycemia, insulin therapy, and severe retinopathy of prematurity (ROP) in extremely low-birth-weight (ELBW) infants. Study Design In this retrospective database study, we included all ELBW infants who were <= 32 weeks gestational age (GA). We excluded infants without any ophthalmology evaluation and infants who died before 28 days of life. A multivariable model was constructed to determine the association between hyperglycemia, insulin use, and severe ROP. We defined hyperglycemia as blood glucose (BG) > 180 mg/dL. Covariates were GA, small for GA status, discharge year, sex, Apgar score at 5 minutes, mechanical ventilation, oxygen use, bacteremia, and postnatal steroid exposure. We defined severe ROP as ROP requiring bevacizumab, cryotherapy, laser therapy, or vitrectomy. Sensitivity analysis using BG > 150 mg/dL and > 200 mg/dL was performed. Results A total of 24,548 infants were included; 2,547 (10%) had severe ROP. Hyperglycemia alone was not associated with severe ROP (odds ratio [OR], 0.88; 95% confidence interval [CI], 0.66-1.17). Hyperglycemia and insulin use were not associated with severe ROP (OR, 1.43; 95% CI, 0.91-2.23). BG > 150 mg/dL and insulin use were associated with severe ROP (OR, 1.34; 95% CI, 1.02-1.76). Conclusions Hyperglycemia alone was not associated with severe ROP in ELBW infants. However, we did observe a possible trend between the use of insulin and severe ROP.
id UFSP_fa346784295c5921a8c45055b17c4bbf
oai_identifier_str oai:repositorio.unifesp.br:11600/57882
network_acronym_str UFSP
network_name_str Repositório Institucional da UNIFESP
repository_id_str 3465
spelling Lee, Jan HauHornik, Christoph P.Testoni, Daniela [UNIFESP]Laughon, Matthew M.Cotten, C. MichaelMaldonado, Ramiro S.Belcastro, Marc R.Clark, Reese H.Smith, P. Brian2020-08-21T17:00:08Z2020-08-21T17:00:08Z2016American Journal Of Perinatology. New York, v. 33, n. 4, p. 393-400, 2016.0735-1631https://repositorio.unifesp.br/handle/11600/57882http://dx.doi.org/10.1055/s-0035-1565999WOS000372062200010.pdf10.1055/s-0035-1565999WOS:000372062200010Objective This study aims to determine the association between hyperglycemia, insulin therapy, and severe retinopathy of prematurity (ROP) in extremely low-birth-weight (ELBW) infants. Study Design In this retrospective database study, we included all ELBW infants who were <= 32 weeks gestational age (GA). We excluded infants without any ophthalmology evaluation and infants who died before 28 days of life. A multivariable model was constructed to determine the association between hyperglycemia, insulin use, and severe ROP. We defined hyperglycemia as blood glucose (BG) > 180 mg/dL. Covariates were GA, small for GA status, discharge year, sex, Apgar score at 5 minutes, mechanical ventilation, oxygen use, bacteremia, and postnatal steroid exposure. We defined severe ROP as ROP requiring bevacizumab, cryotherapy, laser therapy, or vitrectomy. Sensitivity analysis using BG > 150 mg/dL and > 200 mg/dL was performed. Results A total of 24,548 infants were included; 2,547 (10%) had severe ROP. Hyperglycemia alone was not associated with severe ROP (odds ratio [OR], 0.88; 95% confidence interval [CI], 0.66-1.17). Hyperglycemia and insulin use were not associated with severe ROP (OR, 1.43; 95% CI, 0.91-2.23). BG > 150 mg/dL and insulin use were associated with severe ROP (OR, 1.34; 95% CI, 1.02-1.76). Conclusions Hyperglycemia alone was not associated with severe ROP in ELBW infants. However, we did observe a possible trend between the use of insulin and severe ROP.National Center for Advancing Translational Sciences of the National Institutes of Health (NIH)U.S. governmentNational Institute of Child Health and Human DevelopmentNIHNational Center for Advancing Translational Sciences of the NIHU.S. Food and Drug AdministrationCempra PharmaceuticalsDuke Univ, Dept Pediat, Sch Med, Durham, NC 27706 USADuke Univ, Sch Med, Duke Clin Res Inst, Durham, NC USAKK Womens & Childrens Hosp, Childrens Intens Care Unit, Singapore, SingaporeUniv Fed Sao Paulo, Ecola Paulista Med, Div Neonatal Med, Sao Paulo, BrazilUniv N Carolina, Dept Pediat, Chapel Hill, NC USAMEDNAX Inc, Pediat Med Grp, Jacksonville, FL USAUniv Fed Sao Paulo, Ecola Paulista Med, Div Neonatal Med, Sao Paulo, BrazilNIH: UL1TR001117U.S. government: HHSN267200700051CNational Institute of Child Health and Human Development: K23HD068497National Institute of Child Health and Human Development: HHSN275201000003INational Institute of Child Health and Human Development: 1R01-HD081044-01National Center for Advancing Translational Sciences of the NIH: UL1TR001117U.S. Food and Drug Administration: 1R18-FD005292-01Cempra Pharmaceuticals: HHS0100201300009CWeb of Science393-400engThieme Medical Publ IncAmerican Journal Of Perinatologyhyperglycemiaretinopathy of prematurityextremely low birth weightinfantsInsulin, Hyperglycemia, and Severe Retinopathy of Prematurity in Extremely Low-Birth-Weight Infantsinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleNew York334info:eu-repo/semantics/openAccessreponame:Repositório Institucional da UNIFESPinstname:Universidade Federal de São Paulo (UNIFESP)instacron:UNIFESPORIGINALWOS000372062200010.pdfapplication/pdf351274${dspace.ui.url}/bitstream/11600/57882/1/WOS000372062200010.pdf9a57e0c5ec05916d04538acab65fc8caMD51open accessTEXTWOS000372062200010.pdf.txtWOS000372062200010.pdf.txtExtracted texttext/plain32638${dspace.ui.url}/bitstream/11600/57882/2/WOS000372062200010.pdf.txt31bb0546b76bc577e6f6a36e13d22e53MD52open accessTHUMBNAILWOS000372062200010.pdf.jpgWOS000372062200010.pdf.jpgIM Thumbnailimage/jpeg7034${dspace.ui.url}/bitstream/11600/57882/4/WOS000372062200010.pdf.jpg86d9e790e6366e9bf8ee5837a9788a6aMD54open access11600/578822022-07-31 19:43:05.749open accessoai:repositorio.unifesp.br:11600/57882Repositório InstitucionalPUBhttp://www.repositorio.unifesp.br/oai/requestopendoar:34652022-07-31T22:43:05Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)false
dc.title.en.fl_str_mv Insulin, Hyperglycemia, and Severe Retinopathy of Prematurity in Extremely Low-Birth-Weight Infants
title Insulin, Hyperglycemia, and Severe Retinopathy of Prematurity in Extremely Low-Birth-Weight Infants
spellingShingle Insulin, Hyperglycemia, and Severe Retinopathy of Prematurity in Extremely Low-Birth-Weight Infants
Lee, Jan Hau
hyperglycemia
retinopathy of prematurity
extremely low birth weight
infants
title_short Insulin, Hyperglycemia, and Severe Retinopathy of Prematurity in Extremely Low-Birth-Weight Infants
title_full Insulin, Hyperglycemia, and Severe Retinopathy of Prematurity in Extremely Low-Birth-Weight Infants
title_fullStr Insulin, Hyperglycemia, and Severe Retinopathy of Prematurity in Extremely Low-Birth-Weight Infants
title_full_unstemmed Insulin, Hyperglycemia, and Severe Retinopathy of Prematurity in Extremely Low-Birth-Weight Infants
title_sort Insulin, Hyperglycemia, and Severe Retinopathy of Prematurity in Extremely Low-Birth-Weight Infants
author Lee, Jan Hau
author_facet Lee, Jan Hau
Hornik, Christoph P.
Testoni, Daniela [UNIFESP]
Laughon, Matthew M.
Cotten, C. Michael
Maldonado, Ramiro S.
Belcastro, Marc R.
Clark, Reese H.
Smith, P. Brian
author_role author
author2 Hornik, Christoph P.
Testoni, Daniela [UNIFESP]
Laughon, Matthew M.
Cotten, C. Michael
Maldonado, Ramiro S.
Belcastro, Marc R.
Clark, Reese H.
Smith, P. Brian
author2_role author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Lee, Jan Hau
Hornik, Christoph P.
Testoni, Daniela [UNIFESP]
Laughon, Matthew M.
Cotten, C. Michael
Maldonado, Ramiro S.
Belcastro, Marc R.
Clark, Reese H.
Smith, P. Brian
dc.subject.eng.fl_str_mv hyperglycemia
retinopathy of prematurity
extremely low birth weight
infants
topic hyperglycemia
retinopathy of prematurity
extremely low birth weight
infants
description Objective This study aims to determine the association between hyperglycemia, insulin therapy, and severe retinopathy of prematurity (ROP) in extremely low-birth-weight (ELBW) infants. Study Design In this retrospective database study, we included all ELBW infants who were <= 32 weeks gestational age (GA). We excluded infants without any ophthalmology evaluation and infants who died before 28 days of life. A multivariable model was constructed to determine the association between hyperglycemia, insulin use, and severe ROP. We defined hyperglycemia as blood glucose (BG) > 180 mg/dL. Covariates were GA, small for GA status, discharge year, sex, Apgar score at 5 minutes, mechanical ventilation, oxygen use, bacteremia, and postnatal steroid exposure. We defined severe ROP as ROP requiring bevacizumab, cryotherapy, laser therapy, or vitrectomy. Sensitivity analysis using BG > 150 mg/dL and > 200 mg/dL was performed. Results A total of 24,548 infants were included; 2,547 (10%) had severe ROP. Hyperglycemia alone was not associated with severe ROP (odds ratio [OR], 0.88; 95% confidence interval [CI], 0.66-1.17). Hyperglycemia and insulin use were not associated with severe ROP (OR, 1.43; 95% CI, 0.91-2.23). BG > 150 mg/dL and insulin use were associated with severe ROP (OR, 1.34; 95% CI, 1.02-1.76). Conclusions Hyperglycemia alone was not associated with severe ROP in ELBW infants. However, we did observe a possible trend between the use of insulin and severe ROP.
publishDate 2016
dc.date.issued.fl_str_mv 2016
dc.date.accessioned.fl_str_mv 2020-08-21T17:00:08Z
dc.date.available.fl_str_mv 2020-08-21T17:00:08Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.citation.fl_str_mv American Journal Of Perinatology. New York, v. 33, n. 4, p. 393-400, 2016.
dc.identifier.uri.fl_str_mv https://repositorio.unifesp.br/handle/11600/57882
http://dx.doi.org/10.1055/s-0035-1565999
dc.identifier.issn.none.fl_str_mv 0735-1631
dc.identifier.file.none.fl_str_mv WOS000372062200010.pdf
dc.identifier.doi.none.fl_str_mv 10.1055/s-0035-1565999
dc.identifier.wos.none.fl_str_mv WOS:000372062200010
identifier_str_mv American Journal Of Perinatology. New York, v. 33, n. 4, p. 393-400, 2016.
0735-1631
WOS000372062200010.pdf
10.1055/s-0035-1565999
WOS:000372062200010
url https://repositorio.unifesp.br/handle/11600/57882
http://dx.doi.org/10.1055/s-0035-1565999
dc.language.iso.fl_str_mv eng
language eng
dc.relation.ispartof.none.fl_str_mv American Journal Of Perinatology
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv 393-400
dc.coverage.none.fl_str_mv New York
dc.publisher.none.fl_str_mv Thieme Medical Publ Inc
publisher.none.fl_str_mv Thieme Medical Publ Inc
dc.source.none.fl_str_mv reponame:Repositório Institucional da UNIFESP
instname:Universidade Federal de São Paulo (UNIFESP)
instacron:UNIFESP
instname_str Universidade Federal de São Paulo (UNIFESP)
instacron_str UNIFESP
institution UNIFESP
reponame_str Repositório Institucional da UNIFESP
collection Repositório Institucional da UNIFESP
bitstream.url.fl_str_mv ${dspace.ui.url}/bitstream/11600/57882/1/WOS000372062200010.pdf
${dspace.ui.url}/bitstream/11600/57882/2/WOS000372062200010.pdf.txt
${dspace.ui.url}/bitstream/11600/57882/4/WOS000372062200010.pdf.jpg
bitstream.checksum.fl_str_mv 9a57e0c5ec05916d04538acab65fc8ca
31bb0546b76bc577e6f6a36e13d22e53
86d9e790e6366e9bf8ee5837a9788a6a
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
repository.name.fl_str_mv Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)
repository.mail.fl_str_mv
_version_ 1802764129555972096